髋关节移位术可在髋臼周围肿瘤切除后提供早期行走功能:一项多中心研究
日本六家三级中心回顾性纳入38例髋臼周围恶性肿瘤行内半骨盆切除并髋关节移位术的患者,中位随访17个月。术后中位20天用助行器、35天用双拐;术后60天76%可双拐行走,早期恢复组最终MSTS评分更高(57% vs 45%,p=0.047),获得更好功能的可能性更高(HR 15.2)。42%因伤口问题再手术。
要点
- 髋关节移位术后中位20天用助行器、35天用双拐,60天时76%可双拐行走。
- 60天不能双拐行走者最终MSTS评分较低(45% vs 57%,p=0.047)。
- 早期恢复组获得单拐/手杖或更好功能的可能性更高(HR 15.2,95%CI 2.5-93)。
核心结论
- 髋关节移位术后行走功能恢复需要相当时间,术后60天不能双拐行走者似乎较难恢复行走功能且此后MSTS评分可能较低。
- 伤口相关并发症常见。
- 该方法对于有力量进行长期康复或希望尽量减少假体相关并发症的年轻患者可能是现实的选择。
- 需要更多患者的前瞻性研究来了解延迟恢复相关的危险因素。
研究设计与样本
- 2009年至2019年日本六家三级中心回顾性研究,48例恶性肿瘤行内半骨盆切除患者中92%(44/48)接受髋关节移位术。
- 44例中86%(38/44)随访至少6个月、期间无局部复发并纳入分析。
- 选择6个月为最短随访时间,因研究终点关注早期恢复而非重建耐久性。
- 手术将股骨近端(股骨头、转子区切除端及假体等间隔物)上移至切除髂骨下方或骶骨外侧面,用聚乙烯带、聚对苯二甲酸乙二醇酯网、髂胫束移植物或外固定架固定。
- 手术中位年龄46岁(范围9-76岁),女23例、男15例,中位随访17个月(范围6-110个月)。
主要发现
- 患者开始使用助行器中位术后第20天(IQR 14-36),使用双拐中位术后第35天(IQR 20-57)。
- 术后第60天(约中位出院日),76%(29/38)能使用双拐行走(早期恢复组),24%(9/38)不能(延迟恢复组)。
- 两组间无基线因素差异。
- 早期恢复组中位MSTS评分高于延迟恢复组:57%(范围17%-90%)vs 45%(13%-57%)(p=0.047)。
- 早期恢复组更多患者获得更好功能(单拐或手杖或更好),中位5个月(95%CI 4-11),延迟恢复组中位未达到(p=0.0006),HR 15.2(95%CI 2.5-93)。
关键数值与推荐
- 早期恢复定义为术后第60天能使用双拐行走,延迟恢复定义为不能。
- 功能里程碑包括轮椅、助行器、双拐、单拐或手杖、无辅助行走。
- 最终随访时评估MSTS评分。
临床怎么用
- 作者认为该方法对于有力量进行长期康复的年轻患者或希望尽量减少假体相关并发症者可能是现实的选择。
- 作者指出需要更多患者的前瞻性研究来了解延迟恢复相关的危险因素。
局限性
- 本研究为回顾性研究。
- 需要更多患者的前瞻性研究来了解延迟恢复相关的危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reconstruction after periacetabular bone tumor resection involves important tradeoffs; large bone grafts or endoprostheses are reported to offer fair walking function in general but can be technically demanding and carry a high risk of severe complications. Conversely, hip transposition avoids implant-related risks, but stability and functional return may be less consistent. Fewer studies are available on hip transposition, which is also appealing in more resource-constrained environments, and little is known about the time course from surgery to functional return after hip transposition. QUESTIONS/PURPOSES: (1) What is the time course of recovery of walking function after hip transposition, especially in the first 6 months? (2) What factors are associated with a greater likelihood of early functional recovery? (3) Is early (2-month) functional recovery associated with a greater likelihood of walking ability and higher Musculoskeletal Tumor Society (MSTS) scores? METHODS: Between 2009 and 2019, six tertiary care centers in Japan treated 48 patients with internal hemipelvectomy for malignant tumors. During that time, the preferred reconstructive approach was hip transposition, and 92% (44 of 48) of our patients were treated with this procedure. Among them, 86% (38 of 44) had follow-up of at least 6 months, had no local recurrence during that time, and were included in our retrospective study. We chose 6 months as the minimum follow-up duration because the endpoints in this study pertained to early recovery rather than reconstructive durability. Hip transposition involved moving the proximal end of the femur (femoral head, resection end of the trochanteric area, and spacers such as prostheses) upward to the underside of the resected ilium or the lateral side of the sacrum if sacroiliac joint resection was performed. The end of the proximal femur was stabilized to the remaining ilium or sacrum using polyethylene tape, polyethylene terephthalate mesh, an iliotibial tract graft, or an external fixator, according to the surgeon's preference. The median age at surgery was 46 years (range 9 to 76 years), there were 23 women and 15 men, and the median follow-up duration was 17 months (range 6 to 110 months). The postoperative time course of functional recovery was assessed with a record review, the timing of functional milestones was identified (wheelchair, walker, bilateral crutches, single crutch or cane, and walking without an aid), and the MSTS score at the final follow-up was assessed. Additionally, demographic and surgical factors were reviewed, and their association with short-term functional recovery and the final functional outcome was analyzed. RESULTS: Patients started using a walker at median postoperative day (POD) 20 (IQR 14 to 36) and with bilateral crutches at median POD 35 (IQR 20 to 57). At POD 60, which was the approximate median date of discharge, 76% (29 of 38) of patients were able to walk using bilateral crutches (the early recovery group) and 24% (nine of 38) of patients were not able to do so (the delayed recovery group). No baseline factors were different between the two groups. The early recovery group had a higher median MSTS score than the delayed recovery group: 57% (range 17% to 90%) versus 45% (13% to 57%) (p = 0.047). Moreover, more patients acquired better function (a single crutch or cane or more) in the early recovery group, with a median of 5 months (95% CI 4 to 11) than did those in the delayed recovery group (median not reached) (p = 0.0006). The HR was 15.2 (95% CI 2.5 to 93). Forty-two percent (16 of 38) underwent additional surgery for wound management. CONCLUSION: It took patients a fair amount of time to recover walking function after hip transposition, and patients who could not walk on bilateral crutches at POD 60 seemed less likely to regain walking function and were likely to have lower MSTS scores thereafter. Wound-related complications were frequent. This method may be a realistic alternative for younger patients who have the strength for a long rehabilitation period or those who want to minimize prosthesis-related complications. Future studies with more patients are necessary to understand the risk factors associated with delayed recovery.Level of Evidence Level III, therapeutic study.
引用
- Zhang L, Iwata S, Saito M, et al. Hip Transposition Can Provide Early Walking Function After Periacetabular Tumor Resection: A Multicenter Study. Clin Orthop Relat Res. 2023. PMID: 37184605. doi:10.1097/CORR.0000000000002696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。